X

Glenmark’s Sevelamer Hydrochloride Tablets granted final FDA approval

Reports confirm that Glenmark Pharmaceuticals has recently secured a final approval by the U.S. Food…

Ojaswita Kutepatil

Kerecis gains approval for selling Kerecis Omega3 Wound in Switzerland

Switzerland healthcare authorities approve Kerecis Omega3 Wound Kerecis plans to buy Phytoceuticals for establishing sales…

Ojaswita Kutepatil

Cognoa receives FDA breakthrough designation for its digital devices

These digital devices are the basis of Cognoa’s precision health platform. The FDA Breakthrough Device…

Ojaswita Kutepatil

Resonetics acquires medical device manufacturer Caribou Technologies

The latest takeover is in line with the strategy of Resonetics to add new manufacturing…

Ojaswita Kutepatil

Drug magnate Lupin brings Clomipramine Hydrochloride to the U.S.

Pharmaceutical company Lupin has apparently launched the generic version of Clomipramine Hydrochloride capsules in the…

Ojaswita Kutepatil

Copper 3D receives NASA grant for 3D printing of medical devices

The funding has been allotted by NASA Nebraska Space Grant, one of the 52 space…

Ojaswita Kutepatil

CGM-focused Senseonics extends its distribution agreement with Roche

Senseonics Holdings, Inc., a US-based medical technology company, has reportedly announced the extension of its…

Ojaswita Kutepatil

MeiraGTx and Janssen to develop gene therapies for IRD treatments

The latest transaction is the second significant collaboration by the two companies MeiraGTx Holdings Plc,…

Ojaswita Kutepatil

Sanofi’s Fexinidazole approved in DRC for curing sleeping sickness

Fexinidazole would add to the global efforts dedicated to eliminating sleeping sickness, a deadly neglected…

Ojaswita Kutepatil